Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2007
02/15/2007US20070037254 Expression Vectors and Methods
02/15/2007US20070037253 18-Residue dimerized peptide designated PIP [59-67] dimer, having dual inhibitory activity against secretory phospholipase A2 (sPLA2) and matrix metalloproteinases (MMPs); acute pancreatitis; infection; neurodegenerative disease; neuronal excitotoxicity
02/15/2007US20070037251 Novel protein expression system
02/15/2007US20070037248 Production of modified glycoproteins having multiple antennary structures
02/15/2007US20070037247 Polypeptide having a thermostable ribonuclease H activity; highly valuable for genetic engineering
02/15/2007US20070037246 Methods and compositions for enhanced protein expression and purification
02/15/2007US20070037219 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
02/15/2007US20070037218 Human gene critical to fertility
02/15/2007US20070037216 Dual expression vector system for antibody expression in bacterial and mammalian cells
02/15/2007US20070037206 Human secreted proteins
02/15/2007US20070037204 protein encoded by the nucleotide sequence represented by SEQ ID NO: 1 to 65 ; useful for diagnosing and treating cancer
02/15/2007US20070037203 Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
02/15/2007US20070037193 Modulation of peroxisome proliferator-activated receptors
02/15/2007US20070037191 Apo-2DcR
02/15/2007US20070037188 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's diseases; contacting a target cell with a test compound, measuring the levels of reporter gene transcription that occurs in the presence and absence of the test compound; comparing the levels of reporter gene transcription
02/15/2007US20070037182 Multiplex assays for inferring ancestry
02/15/2007US20070037181 Compositions and methods for detecting pathogen specific nucleic acids in urine
02/15/2007US20070037177 CYP19A1 polymorphisms
02/15/2007US20070037168 Polymorphisms in known genes associated with inflammatory autoimmune disease, methods of detection and uses thereof
02/15/2007US20070037165 Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
02/15/2007US20070037164 Tumor necrosis factor alpha
02/15/2007US20070037163 Nucleic acid and amino acid sequences relating to staphylococcus epidermidis for diagnostics and therapeutics
02/15/2007US20070037162 Polymorphisms in known genes associated with osteoporosis, methods of detection and uses thereof
02/15/2007US20070037161 Motoneuronotrophic factor gene sequences
02/15/2007US20070037160 Method for the dissociation of the extracellular haemoglobin molecule of <I> arenicola marina </I> and the characterisation of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains
02/15/2007US20070037159 Tetrahydrofolate synthetase gene
02/15/2007US20070037156 Metalloproteinase gene polymorphism in copd
02/15/2007US20070037149 Human calcium transporter 1 gene, screening method of calcium absorption regulating factor, and calcium absorption regulating factor
02/15/2007US20070037145 drug screening; for carcinomas, especially lymphoma carcinomas
02/15/2007US20070037140 Methods and compositions for detecting sars virus
02/15/2007US20070036819 Plasmodium placental polypeptide for use in generating vaccine for treatment and prevention of malarial infection
02/15/2007US20070036816 Tuberculosis antigen detection assays and vaccines
02/15/2007US20070036815 Ricin-like toxins for treatment of cancer
02/15/2007US20070036814 Antibody binding to polypeptide of given sequence; antisera; use in wound healing, blocking adherence to indwelling medical devices, vaccines
02/15/2007US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders
02/15/2007US20070036812 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine
02/15/2007US20070036810 Cyclic amp response element activator proteins and uses related thereto
02/15/2007US20070036799 Identification and engineering of antibodies with variant Fc regions and methods of using same
02/15/2007US20070036796 For treating immunosuppressive diseases; AIDS
02/15/2007US20070036794 Agonist anti-trkC monoclonal antibodies, directed against epitopes in extracellular domain of trkC receptor, which mimic biological activities of NT-3, the natural ligand of trkC receptor, but are free of some of known detriments of NT-3; use of theseagonist antibodies treatment of neuropathy
02/15/2007US20070036789 Neutralizable Epitope of HGF and Neutralizing Antibody Binding to the Same
02/15/2007US20070036788 Use of a compound for reducing the biological effectiveness of il-6
02/15/2007US20070036782 Apo-2 ligand
02/15/2007US20070036763 Interleukin-17 receptor homologue
02/15/2007US20070036762 Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer
02/15/2007US20070036752 IL-2 fusion proteins with modulated selectivity
02/15/2007US20070036750 MCP1 fusions
02/15/2007US20070036721 Methods and compositions for in vivo inflammation monitoring
02/15/2007DE102005035461A1 Stabile NAD/NADH-Derivate Stable NAD / NADH derivatives
02/15/2007CA2615776A1 Secretion of antibodies without signal peptides from bacteria
02/14/2007EP1752545A2 HIV probes for use in solution phase sandwich hybridization assays
02/14/2007EP1752525A1 Amylase variants
02/14/2007EP1752160A2 Epitope sequences
02/14/2007EP1751316A2 Nucleic acid probes and nucleic acid analog probes
02/14/2007EP1751309A2 Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
02/14/2007EP1751298A1 Methods for dynamic vector assembly of dna cloning vector plasmids
02/14/2007EP1751286A2 Biosynthetic gene cluster for the production of a complex polyketide
02/14/2007EP1751284A2 Method and compositions for detecting botulinum neurotoxin
02/14/2007EP1751280A2 Tobacco nicotine demethylase genomic clone and uses thereof
02/14/2007EP1751279A2 Nucleic acids and polypeptides involved in the production of cryptophycin
02/14/2007EP1751278A2 Nicotiana nucleic acid molecules and uses thereof
02/14/2007EP1751181A1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
02/14/2007EP1750776A2 Oligonucleotides comprising a c5-modified pyrimidine
02/14/2007EP1750771A2 Pancreatic islet microrna and methods for inhibiting same
02/14/2007EP1576144A4 Proteorhodopsin mutants with improved optical characteristics
02/14/2007EP1546380A4 Methods and apparati using single polymer analysis
02/14/2007EP0662077B1 Cd27 ligand
02/14/2007CN1914335A Antisense oligonucleotide modulation of STAT3 expression
02/14/2007CN1914324A Cattle beta-casein gene targeting vector using homologous recombination
02/14/2007CN1914223A Modified human interferon polypeptides and their uses
02/14/2007CN1914222A Methods and compositions for identifying RNA-binding proteins
02/14/2007CN1913921A Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
02/14/2007CN1912141A Identification of genes
02/14/2007CN1912135A RNA affinity media and preparation method thereof
02/14/2007CN1912124A Ring-shaped micro-chromosome of rice and its obtaining method
02/14/2007CN1912119A Human HS5 AR-iso gene sequence, its coded protein and preparation method
02/14/2007CN1912112A Recombinant infectious non-segmented negative strand rna virus
02/14/2007CN1911957A Series polypeptide of blood pressure lowering peptide, expression carrier, polynucleotide sequence and application
02/14/2007CN1300319C Nucleotide specific to 0174 type O antigen of bacillus coli
02/14/2007CN1300315C Prothoracic gland hormone gene of calf of milk cow and its cloning method and use
02/14/2007CN1300313C Clone of gene MAC30 related to pig backfat thickness and its use in mark-assisted selection
02/14/2007CN1300312C Structure and use of anti-hypatitis B virus antisense oligonucleotide of target de-sialoglycoprotein receptor
02/14/2007CN1300170C Novel DnaJ/Hsp40 molecule DC-DJIII, its coding sequence and application
02/14/2007CN1300166C Method for extracting RNA from cotton tissue
02/13/2007US7176482 DNA-based electronics
02/13/2007US7176355 Ribosomal RNA regulatory sequences for use as tools in controlling heterologous gene expression; chloroplast transcription modulating element; tissue engineering
02/13/2007US7176354 Genes encoding sulfate assimilation proteins
02/13/2007US7176353 Genes encoding sulfate assimilation proteins
02/13/2007US7176348 Cocoa polypeptides and their use in the production of cocoa and chocolate flavor
02/13/2007US7176304 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; used in therapeutic, diagnostic, target validation, and genomic discovery
02/13/2007US7176303 Modulation of STAT5 expression
02/13/2007US7176302 Delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome and is
02/13/2007US7176300 Avian lysozyme promoter
02/13/2007US7176299 Compounds
02/13/2007US7176298 Polynucleotides encoding metal ion affinity peptides and related products
02/13/2007US7176297 Photoactivatable silane compounds and methods for their synthesis and use
02/13/2007US7176296 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
02/13/2007US7176295 Systematic evolution of ligands by exponential enrichment: blended SELEX
02/13/2007US7176294 Transcription factor, BP1
02/13/2007US7176293 A novel cell cycle gene and its uses in diagnosis and drug screening, the protein encoded regulating the transition of cells from prophase to metaphase; the absence of the chfr nucleic acid sequence indicates that the cell is sensitive to mitotic stress or its tumorigenic potential; kits